Fund overview & performance

Looking for segregated funds?

Canada Life Segregated Funds

Canada Life U.S. Value Fund

Fund profile and commentary

Fund fact

May 31, 2025

A U.S. large-cap value fund seeking long-term growth.

Is this fund right for you?

You want your money to grow over a longer term.
You want to invest in U.S. equities.
You're comfortable with a medium level of risk.

Risk Rating

How is the fund invested? (as of March 31, 2025)

Asset allocation (%)

	Name	Percent
	US Equity	87.0
	International Equity	9.4
	Cash and Equivalents	3.2
	Canadian Equity	0.4

Geographic allocation (%)

	Name	Percent
	United States	87.0
	Ireland	5.1
	Canada	3.6
	United Kingdom	2.6
	France	1.6
	Other	0.1

Sector allocation (%)

	Name	Percent
	Financial Services	19.3
	Healthcare	14.4
	Consumer Goods	11.7
	Industrial Goods	9.2
	Consumer Services	7.9
	Technology	6.8
	Energy	6.5
	Telecommunications	5.0
	Utilities	4.2
	Other	15.0

Growth of $10,000 (since inception)

Data not available based on date of inception

Fund details (as of March 31, 2025)

Top holdings	%
Cash and Cash Equivalents	3.2
Philip Morris International Inc	3.0
Citigroup Inc	2.9
Exxon Mobil Corp	2.9
Walmart Inc	2.9
Abbvie Inc	2.9
Coca-Cola Co	2.8
UnitedHealth Group Inc	2.5
Bank of America Corp	2.4
McKesson Corp	2.3
Total allocation in top holdings	27.8

Portfolio characteristics
Standard deviation	13.3%
Dividend yield	2.3%
Average market cap (million)	$349,755.1

Understanding returns

Annual compound returns (%)

1 MO	3 MO	YTD	1 YR
{{snapShot.Return1Mth\|customNumber:1}}	{{snapShot.Return3Mth\|customNumber:1}}	{{snapShot.ReturnYTD\|customNumber:1}}	{{snapShot.Return1Yr\|customNumber:1}}

3 YR	5 YR	10 YR	INCEPTION
{{snapShot.Return3Yr\|customNumber:1}}	{{snapShot.Return5Yr\|customNumber:1}}	{{snapShot.Return10Yr\|customNumber:1}}	{{snapShot.ReturnInception\|customNumber:1}}

Calendar year returns (%)

2024	2023	2022	2021
{{snapShot.Return1YrCalendar\|customNumber:1}}	{{snapShot.Return2YrCalendar\|customNumber:1}}	{{snapShot.Return3YrCalendar\|customNumber:1}}	{{snapShot.Return4YrCalendar\|customNumber:1}}

2020	2019	2018	2017
{{snapShot.Return5YrCalendar\|customNumber:1}}	{{snapShot.Return6YrCalendar\|customNumber:1}}	{{snapShot.Return7YrCalendar\|customNumber:1}}	{{snapShot.Return8YrCalendar\|customNumber:1}}

Range of returns over five years (August 1, 2017 - May 31, 2025)

Best return	Best period end date	Worst return	Worst period end date
19.4%	March 2025	9.1%	Sept. 2022

Average return	% of periods with positive returns	Number of positive periods	Number of negative periods
12.5%	100.0%	35	0

Q1 2025 Fund Commentary

Market commentary

U.S. large-capitalization value stocks rose in the first quarter, while broader equity markets declined. The release of artificial intelligence (AI) models developed by Chinese company DeepSeek led investors to question the AI spending outlook. Geopolitical and economic concerns led to higher financial market volatility. The U.S. administration’s tariff policy rollout contributed to uncertainty throughout the quarter.

Performance

The Fund’s overweight exposure to Philip Morris International Inc., AbbVie Inc. and McKesson Corp. was positive for performance. Relative exposure to Microsoft Corp. and Oracle Corp. was negative for performance. The Fund’s lack of exposure to Berkshire Hathaway Inc. was also negative for performance.

At the sector level, stock selection in consumer staples, industrials, communication services and health care had a positive impact on the Fund’s performance. Overweight exposure to consumer staples and health care, and underweight exposure to industrials and information technology, were also positive for performance. Stock selection in information technology, financials and consumer discretionary was negative for performance. Underweight exposure to energy and communication services was also negative as these sectors outperformed.

Portfolio activity

The sub-advisor added Accenture PLC, The Allstate Corp. and Seagate Technology Holdings PLC to the Fund. Holdings in Thermo Fisher Scientific Inc., Philip Morris International Inc. and Regeneron Pharmaceuticals Inc. were increased.

NXP Semiconductors NV, Vontier Corp. and Kenvue Inc. were sold. Positions in Boston Scientific Corp., AXA SA, Oracle Corp. and Walmart Inc. were reduced.

Outlook

As the first quarter of 2025 ended, the U.S. administration’s tariff policies continued to create uncertainty for financial markets. Riskier assets declined sharply, and the potential for an economic recession increased. While some areas of the market are directly affected by U.S. tariff policies, stocks that are less exposed have also declined. In the sub-advisor’s view, this environment could present unique buying opportunities.

At the end of the quarter, the Fund’s largest overweight exposures were to consumer staples, materials and health care. The Fund had underweight exposure to real estate and industrials.

(September 30, 2024)

Putnam Investments

NL — MAX2123

Contact information

Toll free: 1-844-730-1633

Period:

From: to:

Chart type:

Simple moving average:

No matching records found.

Summary

For the period {{NAVPSPerformanceSummary.StartDate}} through {{NAVPSPerformanceSummary.EndDate}} with $10,000 CAD investment

Total returns performance

Last price

{{NAVPSPerformanceSummary.NAVPS | customCurrency}} CAD

as of market close {{NAVPSPerformanceSummary.NAVPSDate}}

Value of $10,000 investment

{{NAVPSPerformanceSummary.GrowthOfTenThousand | customCurrency}} CAD

Period:

From: to:

Interval:

Export to:

Legal disclaimers

The commentaries on the company specific information and purchases and sales were provided by the fund manager. Canada Life Investment Management Ltd. will not be liable for any loss, or damages whatsoever, whether directly or indirectly incurred, arising out of the use or misuse of errors or omissions in any information contained in this commentary. The data provided in this commentary is for information purposes only and, except where otherwise indicated, is current as of March 31, 2025.

The views expressed in this commentary are those of fund manager as at the date of publication and are subject to change without notice. This commentary is presented only as a general source of information and is not intended as a solicitation to buy or sell specific investments, nor is it intended to provide tax or legal advice. Prospective investors should review the offering documents relating to any investment carefully before making an investment decision and should ask their Advisor for advice based on their specific circumstances.

The content of this commentary (including facts, views, opinions, recommendations, descriptions of or references to, products or securities) is not to be used or construed as investment advice, as an offer to sell or the solicitation of an offer to buy, or an endorsement, recommendation or sponsorship of any entity or security cited. Although we endeavour to ensure its accuracy and completeness, we assume no responsibility for any reliance upon it.

This document may contain forward-looking information which reflect our or third-party current expectations or forecasts of future events. Forward-looking information is inherently subject to, among other things, risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed herein. These risks, uncertainties and assumptions include, without limitation, general economic, political and market factors, interest and foreign exchange rates, the volatility of equity and capital markets, business competition, technological change, changes in government regulations, changes in tax laws, unexpected judicial or regulatory proceedings and catastrophic events. Please consider these and other factors carefully and not place undue reliance on forward-looking information. The forward-looking information contained herein is current only as of March 31, 2025. There should be no expectation that such information will in all circumstances be updated, supplemented or revised whether as a result of new information, changing circumstances, future events or otherwise.

There can be no assurance that the Fund’s return or volatility targets will be met, or met over any particular time horizon. Targeted returns and volatility should be evaluated over the time period indicated and not over shorter periods. Targeted returns are not actual performance and should not be relied upon as an indication of actual or future performance.

Canada Life Mutual Funds are managed by Canada Life Investment Management Ltd. offered exclusively through Quadrus Investment Services Ltd., IPC Investment Corporation and IPC Securities Corporation. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently, and past performance may not be repeated.

Canada Life Mutual Funds, Canada Life Investment Management and design, and Canada Life and design are trademarks of The Canada Life Assurance Company.

^Deferred Sales Charge (DSC) and Low Load Deferred Sales Charge (LSC) purchase options is closed to new investments given regulatory bans put in place for these purchase options that came into effect June 1, 2022.

^†Soft capped - Contributions are no longer accepted to new investors.

^‡Hard capped - Contributions are no longer accepted.

Distribution of the chart, history standard and short-term reports are not permitted without including the fund profile long-term report. For money market fund reports: The current yield is an annualized historical yield based on the seven-day period ended on the date noted above and does not represent an actual one-year return. Reports produced using this website are for information purposes only. Canada Life Investment Management Ltd., and their affiliates, representatives, and third party content providers do not warrant the accuracy, completeness, or timeliness of this website or any content, and shall not be responsible for investment decisions, damages, or other losses resulting from the use of this website or its content. The only true report on unit values is the periodic statement prepared and sent by the mutual fund company. Important information about Canada Life Mutual Funds is found in Fund Facts. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and does not take into account sales, redemption, distribution or optional charges or income taxes payable by any unitholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. Money market fund units are not covered by the Canada Deposit Insurance Corporation or by any other government deposit insurer. There can be no assurances that the fund will be able to maintain its net asset value per unit at a constant amount or that the full amount of your investment in the fund will be returned to you. Past performance of the funds may not be repeated. Canada Life Mutual Funds are managed by Canada Life Investment Management Ltd. offered exclusively through Quadrus Investment Services Ltd., IPC Investment Corporation and IPC Securities Corporation.

Fund overview & performance

Asset class

Annualized returns

Fund management

Series